The impact of sofosbuvir/ledipasvir on chronic hepatitis C-infected paediatric patients: a Middle East single-centre experience
Saved in:
Main Authors: | Mohammad Fadhil Ibraheem, Falah Kareem |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2023-11-01
|
Series: | Gastroenterology Review |
Subjects: | |
Online Access: | https://www.termedia.pl/The-impact-of-sofosbuvir-ledipasvir-on-chronic-r-nhepatitis-C-infected-paediatric-patients-r-na-Middle-East-single-centre-experience,41,51709,1,1.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-life study on the effectiveness and safety of sofosbuvir/velpatasvir-based antiviral agents for hepatitis C eradication in Chinese patients
by: Jiayi Wang, et al.
Published: (2024-12-01) -
Real-world effectiveness of sofosbuvir/velpatasvir, glecaprevir/pibrentasvir, and sofosbuvir/velpatasvir/voxilaprevir against genotype 3 hepatitis C virus infection: a systematic review and meta-analysis
by: Liwei Zhuang, et al.
Published: (2025-02-01) -
Ocular manifestations and treatment safety in hepatitis C patients undergoing direct-acting antiviral therapy: a prospective cohort study
by: Guilherme Thomé de Carvalho, et al.
Published: (2025-02-01) -
An Unexpected Interaction between Sofosbuvir/Ledipasvir and Atorvastatin and Colchicine Causing Rhabdomyolysis in a Patient with Impaired Renal Function
by: Shyam Patel, et al.
Published: (2016-01-01) -
Predictors of response to daclatasvir in addition to sofosbuvir in hepatitis C virus-infected patients with stage 4 and 5 chronic kidney disease and patients on maintenance hemodialysis
by: Rasha Gawish, et al.
Published: (2025-01-01)